News Conference News ESC Heart Failure 2024 SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM Michael O'Riordan May 13, 2024
News Daily News Pacemaker Doesn’t Harm Outcomes of Alcohol Septal Ablation for Obstructive HCM Todd Neale September 15, 2022
News Conference News ESC Heart Failure 2022 Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE Todd Neale May 31, 2022
News Conference News ACC 2021 ‘Enormous’ QoL Improvements With Mavacamten in HCM Shelley Wood May 15, 2021
News Conference News ESC 2020 EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class Michael O'Riordan August 29, 2020
News Daily News Preemptive Alcohol Septal Ablation May Help Prevent LVOT Obstruction in TMVR Yael L. Maxwell July 11, 2019
News Daily News Las Pruebas Genéticas No son Necesariamente la Prueba Concluyente en el Diagnóstico de la CMH Yael L. Maxwell August 23, 2016
News Daily News Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis Yael L. Maxwell August 23, 2016
News Daily News MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes Shelley Wood June 14, 2016
News Daily News Survival After Septal Ablation for HOCM Similar to General Population L.A. McKeown February 06, 2014
News Daily News La Ablación Septal con Alcohol Rivaliza con la Miectomía en el Tratamiento de la Cardiomiopatía Hipertrófica Obstructiva L.A. McKeown October 23, 2012
News Daily News Alcohol Septal Ablation Rivals Myectomy for Obstructive Hypertrophic Cardiomyopathy L.A. McKeown October 23, 2012
News Daily News Percutaneous Septal Ablation for Hypertrophic Obstructive Cardiomyopathy Shows Low Mortality L.A. McKeown May 27, 2011